baber/WOPTO huggingface dataset:
Patent AU-2017324430-A1 (AU)
Title: Current generation architecture for an implantable medical device
Inventor: WEERAKOON PUJITHA
IPC: A61N1/36
Filed: 2017-09-06
Abstract: An implantable pulse generator (IPG) is disclosed having a plurality of electrode nodes, each electrode node configured to be coupled to an electrode to provide stimulation pulses to a patient's tissue. The IPG includes a digital-to-analog converter configured to amplify a reference current to a first current specified by first control signals; a first resistance configured to receive the first current, wherein a voltage across the first resistance is held to a reference voltage at a first node; a plurality of branches each comprising a second resistance and configured to produce a branch current, wherein a voltage across each second resistance is held to the reference voltage at second nodes; and a switch matrix configurable to selectively couple any branch current to any of the electrode nodes via the second nodes.
Patent AU-2017330448-A1 (AU)
Title: Techniques for WLAN measurements for unlicensed spectrum communications
Inventor: OZTURK OZCAN
IPC: H04L5/00
Filed: 2017-09-25
Abstract: A method and apparatus provide for configuring WLAN measurements for unlicensed spectrum communications. The method and apparatus include receiving, at a network entity, a UE capability message and a reporting message from a UE, determining whether the UE is capable of communicating over the unlicensed spectrum and supports WLAN measurements based on the UE capability message and the reporting message, and transmitting, to the UE, a measurement configuration message including a measurement configuration identifier in accordance with the determination that the UE is capable of communicating over the unlicensed spectrum and supports WLAN measurements. The method and apparatus further include receiving, at a UE, a measurement configuration message and a measurement purpose message from a network entity, determining a measurement configuration of the UE based on the measurement purpose message, and performing one or more measurements for the one or more WLAN access points.
Patent AU-2017355691-A1 (AU)
Title: Network and connected devices for emergency response and roadside operations
Inventor: JACKSON COLE
IPC: G05B19/418
Filed: 2017-11-07
Abstract: A self-assembling network is configured to automatically and dynamically connect devices used in operations carried out on or near roads bearing vehicle and pedestrian traffic. An automatic, ad hoc network connecting existing and new devices can be used to enhance safety by gathering and exchanging safety critical information. In some cases, existing equipment can be augmented with a network controller and radio frequency communications to permit the devices to join a wireless local network and exchange information over the network. New devices, including wearable devices, can be configured to act as nodes on the wireless local network. Establishing the relative position of vehicles, sensors, wearables, and other nodes on the disclosed ad hoc wireless network allows the coordination of functions based on position.
Patent AU-2017384134-A1 (AU)
Title: Combination of a protein kinase inhibitor and an additional chemotherapeutic agent
Inventor: DAMSTRUP LARS
IPC: A61K31/282
Filed: 2017-12-18
Abstract: Combination therapy for the treatment of cancer.
Patent AU-2017413681-A1 (AU)
Title: System and method for evaluating a formation using a statistical distribution of formation data
Inventor: DONG WEIXIN
IPC: E21B47/00
Filed: 2017-05-08
Abstract: A system and method of evaluating a subterranean earth formation using a statistical distribution of formation data. The system comprises a logging tool and a processor in communication with the logging tool. The logging tool comprises a sensor operable to measure formation data and is locatable in a wellbore intersecting the subterranean earth formation. The processor is operable to calculate inversion solutions to the formation data, wherein each inversion solution comprises values for a parameter of the formation, and generate a statistical distribution of the parameter along one or more depths in the subterranean earth formation using the inversion solutions. The processor is also operable to identify peaks within the statistical distribution and select the inversion solutions corresponding to the identified peaks, generate a formation model using the selected inversion solutions; and evaluate the formation using the formation model to identify formation layers for producing a formation fluid.
Patent AU-2017423053-A1 (AU)
Title: Pharmaceutical compositions, methods for preparation using lipid vesicle particles of defined size, and uses thereof
Inventor: SAMMATUR LEELADHAR
IPC: A61K9/127
Filed: 2017-11-09
Abstract: The present disclosure relates to methods for preparing a dried preparation comprising lipids and a therapeutic agent by using lipid vesicle particles having a mean particle size of ≤ 120 nm and a polydispersity index (PDI) of ≤ 0.1. The present application also provides stable, water-free pharmaceutical compositions comprising one or more lipid-based structures having a single layer lipid assembly, at least one therapeutic agent, and a hydrophobic carrier, as well as methods of treatment, uses and kits relating thereto, such as for example for inducing an antibody and/or CTL immune response.
Patent WO-2018195604-A1 (WO)
Title: Convertisseur de courant
Inventor: TRUNINGER RETO
IPC: H02M7/00
Filed: 2018-04-27
Abstract: L'invention concerne un dispositif d'alimentation électrique destiné à convertir une entrée de courant alternatif ( CA) en une sortie de courant continu (CC) et comprenant un module redresseur connecté à l'entrée de courant alternatif pour produire un courant redressé; un convertisseur continu-continu à dernier étage pour produire la sortie de courant continu; et un ou plusieurs étages de lissage disposés entre le module redresseur et le convertisseur continu-continu à dernier étage pour lisser le courant redressé. Un module convertisseur continu-continu initial est disposé entre le redresseur et l'un des étages de lissage pour abaisser la plage de tension du signal de sortie provenant du redresseur. La plage de tension abaissée du courant redressé est fournie directement au convertisseur continu-continu à dernier étage, sans qu'un dispositif de stockage de courant stocke le courant redressé à plage de tension abaissée.
Patent AU-2018204623-A1 (AU)
Title: Fluid injection
Inventor: WEITZ DAVID A
IPC: B01F5/06
Filed: 2018-06-26
Abstract: A microfluidic apparatus for injecting a fluid into a pre-existing droplet, the apparatus comprising: a first microfluidic channel; a second microfluidic channel contacting the first microfluidic channel at an intersection, wherein the second microfluidic channel connects to the intersection via an orifice having an area of no more than about 90% of the average cross-sectional dimension of the second microfluidic channel; and first and second electrodes positioned on the same side or opposing sides of the first microfluidic channel and the second microfluidic channel.
Patent AU-2018225833-A1 (AU)
Title: Apparatus, system and method for detecting a subject's susceptibility to injury
Inventor: ADOLPHE MARGARET KIM
IPC: A61B9/00
Filed: 2018-02-23
Abstract: The present disclosure provides a testing device for testing a subject's susceptibility to injury. The testing device may comprise a base for supporting a frame and an actuator that is supported by the frame, the actuator is configured to impart a physical perturbation upon or proximal a target body-part of the subject. The testing device may also comprise a movement-sensing component for attaching to the tested body-part, the movement-sensing component for detecting the subject's movement after the physical perturbation of the target body-part. The present disclosure also provides a system that includes the testing device and a processor for operating software applications for monitoring and tracking the subject's test data. The present disclosure also provides a method for operating the testing device and system. The present disclosure also provides an apparatus for modifying the stability of a joint of a subject.
Patent AU-2018235626-A1 (AU)
Title: Cooling device and production method for rail
Inventor: OKUSHIRO KENJI
IPC: C22C38/60
Filed: 2018-03-14
Abstract: The purpose of the present invention is to provide a cooling device and a production method for a rail such that a rail having high hardness and high toughness can be produced at a low cost. The present invention provides a cooling device (2) for forced cooling of a rail (1) in an austenitic temperature range by spraying a cooling medium on a head section (11) and a foot section (12) of the rail (1), said cooling device being provided with: a first cooling unit (21) having multiple first cooling headers (211a through 211c) for spraying the cooling medium in a gaseous state on a head top surface and head side surfaces of the head section (11) and first drive units (213a through 213c) for changing the spraying distances of the cooling medium sprayed from the first cooling headers (211a through 211c) by moving at least one of the first cooling headers (211a through 211c) among the multiple first cooling headers (211a through 211c); and a second cooling unit (22) having a second cooling header (221) for spraying the cooling medium in a gaseous state on the foot section (12).
Patent AU-2018238302-A1 (AU)
Title: Expression and large-scale production of peptides
Inventor: GUPTA SUDHARTI
IPC: C07K14/605
Filed: 2018-03-20
Abstract: The invention provides a method for the large-scale preparation of small peptides using recombinant DNA technology. Overexpression of small peptides, such as liraglutide precursor, as concatemers, improves the overall efficiency of the process due to increased yields per batch of the biologically active peptide. Digestion of these concatemers by combinations of specific enzymes yields the desired peptide monomer in large quantities. More particularly, the invention relates to the production of recombinant peptide precursor of liraglutide.
Patent AU-2018240577-A1 (AU)
Title: Novel recombinant adeno-associated viral vectors restricting off-target transduction in liver and uses thereof
Inventor: CAO LEI
IPC: A61K48/00
Filed: 2018-03-26
Abstract: Disclosed are compositions and methods related to novel adeno-associated virus vectors comprising two expression cassettes, wherein the first cassette comprises a regulatory element and a transgene operatively linked to a promoter; and wherein the second cassette comprises a liver specific promoter operatively linked to a microRNA that targets the regulatory element in the first expression cassette.
Patent AU-2018304462-A1 (AU)
Title: Enhanced aero diesel engine
Inventor: FUCHS MICHAEL J
IPC: F02F1/10
Filed: 2018-07-20
Abstract: A ferritic aero diesel engine. The ferritic aero diesel engine includes an iron crankcase, a steel crankshaft and eight steel piston assemblies. The iron crankcase has a flat, horizontally opposed eight cylinder arrangement with a first set of cylinder walls defining a first set of cylinders in a first bank and a second set of cylinder walls defining a second set of cylinders in an opposed second bank. The steel crankshaft is rotatably mounted at least partially within the iron crankcase. Each of the steel piston assemblies of the plurality of steel piston assemblies is received within a respective cylinder of the iron crankcase and is coupled to the steel crankshaft. The first and second sets of cylinder walls have a minimum wall thickness of between approximately 4.8 and 5.2 mm.
Patent AU-2018307480-A1 (AU)
Title: Organic compounds
Inventor: SNYDER GRETCHEN
IPC: A61K31/55
Filed: 2018-07-20
Abstract: The invention relates to particular prodrugs of substituted heterocycle fused gamma-carbolines, in free, solid, pharmaceutically acceptable salt and/or substantially pure form as described herein, pharmaceutical compositions thereof, and methods of use in the treatment of diseases involving the 5-HT
Patent AU-2018337657-A1 (AU)
Title: Electronic park brake interface module, park brake controller and system
Inventor: ZULA DANIEL P
IPC: B60T7/08
Filed: 2018-09-18
Abstract: Various examples of park brake interface modules which are utilized as human machine interfaces (HMI) in vehicles are provided. In one example, a park brake interface module for a vehicle includes an actuation member mounted to an electromechanical switch to actuate the park brake. The actuation member includes a finger pad opposite the front surface and the actuation member is movable between a brake apply position and a brake release position to actuate the vehicle park brake. In another example, the actuation member is pivotally mounted to the electromechanical switch device and the actuation member is pivotable between the brake apply position and the brake release positions to actuate the park brake.
Patent AU-2018360256-A1 (AU)
Title: Apparatus and method for brewing infusion material
Inventor: DUBIEF FLAVIEN FLORENT
IPC: A47J31/20
Filed: 2018-10-30
Abstract: The invention concerns an apparatus (1) for brewing infusion material, said infusion material being hold in a filtering packet (2), said apparatus comprising : - a brew container (11) configured for holding water and a filtering packet of infusion material, and10 - a basket (12) configured for holding the filtering packet and configured for being hold in the brew container, and - an actuator (13) to rotate the basket inside the brew container.
Patent AU-2018367552-A1 (AU)
Title: Cell populations comprising CD31-positive, CD45-negative, CD200-positive mammalian cells, and use thereof
Inventor: TAKAKURA NOBUYUKI
IPC: A61P7/04
Filed: 2018-11-15
Abstract: Provided are: a cell population which is essentially formed from mammalian cells in which cell surface markers CD31 and CD200 are positive, and cell surface marker CD45 is negative; a cell population which is essentially formed from mammalian cells in which cell surface markers CD31, CD157, and CD200 are positive, and cell surface marker CD45 is negative; mammalian vascular endothelial stem cells in which cell surface marker CD31 is positive, cell surface marker CD157 and/or cell surface marker CD200 are/is positive, and cell surface marker CD45 is negative; and a revascularizing pharmaceutical having, as an active ingredient, the cell populations or the vascular endothelial stem cells.
Patent WO-2020056465-A1 (WO)
Inventor: WORTHLEY STEPHEN
IPC: A61M25/01
Filed: 2019-09-20
Abstract: The disclosure generally relates to adjustable sheath devices for insertion into the body to provide intravascular access to various medical devices, involving a dynamically expandable sheath capable of expanding within the blood vessel when a medical device is passed through the sheath and retracting back to almost its original size when the medical device is removed from the sheath. Embodiments generally comprise a rigid collar and an elongated sleeve comprising a continuous elastomeric outer layer and an expandable inner layer.
Patent AU-2019200105-A1 (AU)
Title: Orifice plates
Inventor: VAN BUSKIRK PAUL
IPC: G01F1/44
Filed: 2019-01-08
Abstract: ORIFICE PLATES Abstract Implementations of an orifice plate used to regulate flow through a conduit are provided. In some implementations, a balanced restriction orifice (BRO) plate configured to maximize pressure loss is provided. In some implementations, the BRO plate may be configured to limit pipe and plate noise, erosion, cavitation, shear stress, etc. while maximizing pressure loss, and limiting flow to required values. In some implementations, openings through a BRO plate may be configured to satisfy a Velocity-Head Pres - sure-Loss equation. Alternatively, in some implementations, the hole pattern of an orifice plate may be optimized through the use of a provided Reynolds matching (RM) equation. In some implementations, an orifice plate may be optimized to improve process variable measurements, minimize system pressure drop, recover pressure, and reduce noise and other inefficiencies within the system using equations provided herein. VIEW A-A 200a -102
Patent AU-2019203627-A1 (AU)
Title: Topical pharmaceutical compositions
Inventor: BEDARD Mary
IPC: A61K9/107
Filed: 2019-05-23
Abstract: The present invention relates to topical pharmaceutical emulsion compositions comprising a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof, an oil phase, a water phase, a surfactant, and an antioxidant, and wherein the emulsion composition is homogeneous and/or the active is solubilized in the oil phase. The invention also relates to methods of treating a dermatological condition or disorder in a patient by administering the present compositions to the skin of the patient.
Patent AU-2019203754-A1 (AU)
Title: Hepatitis B core protein allosteric modulators
Inventor: TURNER WILLIAM W
IPC: A01N43/00
Filed: 2019-05-29
Abstract: The present disclosure provides, in part, compounds having allosteric effector properties against Hepatitis B virus Cp. Also provided herein are methods of treating viral infections, such as hepatitis B, comprising administering to a patient in need thereof a disclosed compoumd.
Patent AU-2019204654-A1 (AU)
Title: Method for preparing cell targeting conjugates, and the complexes obtained
Inventor: HOUTHOFF HENDRIK JAN
IPC: A61K49/00
Filed: 2019-06-28
Abstract: A first aspect of the present invention relates to a method for preparing cell targeting conjugates by coupling at least one functional moiety, such as a therapeutic compound, 5 diagnostic compound or chelating agent to a targeting moiety. A second aspect of the present invention relates to the cell targeting conjugates obtainable with said method. A third aspect of the present invention relates to pharmaceutical compositions comprising said cell targeting conjugates. 96945011 (GHMatters) P97487.AU.1 16/11/17
Patent AU-2019205091-A1 (AU)
Title: Betulin-containing birch bark extracts and their formulation
Inventor: WATSON JOHN ASHLEIGH
IPC: A61K9/107
Filed: 2019-01-04
Abstract: The present disclosure relates to birch bark extracts, methods of producing such extracts, stable pharmaceutical compositions containing such extracts and methods of using of such extracts. The birch bark extracts of the present disclosure contain triterpenes, which are known to improve wound healing.
Patent AU-2019214969-A1 (AU)
Title: Instruments, devices and consumables for use in a workflow of a smart molecular analysis system
Inventor: POTHINI SHAKILA
IPC: B01L3/00
Filed: 2019-01-30
Abstract: A system for performing a molecular analysis workflow includes a reaction holder or a reaction substrate, such as a multi-well reaction plate, with a reaction holder/substrate RFID tag, and/or a reagent container with a reagent container RFID tag, and an instrument and/or device that includes an RFID reader/writer operable to read and/or write information to and from the reaction holder/substrate RFID tag and/or the reagent container RFID tag. The reaction holder/substrate RFID tag and the reagent container RFID tag can be utilized separately or together to send and receive and store information, for example, for a workflow of a molecular analysis, such as a polymerase chain reaction (PCR).
Patent AU-2019225271-A1 (AU)
Title: Scroll fluid machine
Inventor: SATO HAJIME
IPC: F01C1/02
Filed: 2019-01-11
Abstract: In a scroll compressor (1) provided with a fixed scroll (3) and an orbiting scroll (5), an inclined section is provided in which the facing-surface distance (L) between an end plate (3a) and an end plate (5a) that face each other decreases continuously from the outer peripheral side towards the inner peripheral side. In grooves formed in the tooth tip of walls (3b, 5b), tip seals are provided that seal a fluid by contacting the opposite tooth bottom. Defining ρ as the turning radius of the orbiting scroll 5 and φ as the incline in the swirl direction of the inclined section, the amount of change in the tip clearance (ΔT) is set to ΔT = 2ρ×tanφ, and the amount of change in the tip clearance (ΔT) is less than or equal to 50% of the height dimension of the tip seal.
Patent AU-2019228421-A1 (AU)
Title: System and method for securing data communication between computers
Inventor: DONSOMSAKUNKIJ MUTITA
IPC: H04L9/08
Filed: 2019-02-28
Abstract: An aspect of the present disclosure generally relates to a computer system (100) and method (200) for securing data communication between a first computer (110) and a second computer (120). The method (200) comprises: cooperatively executing (202), by the first computer (110) and the second computer (120), a first data communication instruction for communicating first data from the first computer (110) to the second computer (120); generating (204) a first session key by the first computer (110); encrypting (206), by the first computer (110) the first data using the first session key; encrypting (208), by the first computer (110) the first session key using a first public key, the first public key paired with a first private key which are generated for the second computer (120); sending (210) the encrypted first data and first session key from the first computer (110) to the second computer (120); decrypting (212), by the second computer (120), the encrypted first session key using the first private key; decrypting (214), by the second computer (120) the encrypted first data using the decrypted first session key; and processing (216), by the second computer (120), the decrypted first data based on the first data communication instruction.
Patent AU-2019228917-A1 (AU)
Title: Pharmaceutical composition, package, and method for manufacturing same
Inventor: HIGUCHI MINE
IPC: A61P43/00
Filed: 2019-02-27
Abstract: Provided are: a pharmaceutical composition comprising a lyophilized glycolytic enzyme having an excellent titer; and a package that comprises said pharmaceutical composition. This pharmaceutical composition is a unit dose formulation which comprises a lyophilized glycolytic enzyme having a titer of at least 0.3 unit/μg as an active ingredient, and which contains the glycolytic enzyme in an amount of 2-8 μg.
Patent AU-2019254680-A1 (AU)
Title: Compounds and their uses for alleviating menopause-associated symptoms
Inventor: TAZIAUX MELANIE
IPC: A61K31/565
Filed: 2019-04-19
Abstract: The present invention relates to a hormone replacement therapy, to the associated compounds and to the associated packaging units,for alleviating menopause-associated symptoms which is based on the administration to a female mammal of an estetrol component at specified daily doses, optionally in combination with a progestogenic component. The therapy enjoys a statistically significant efficacy combined with a favourable profile for side effects compared to currently available methods for alleviating menopause-associated symptoms.